Clinical trial
A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With…
NCT00280696 · UCB Japan Co. Ltd., Industry · Completed
Key facts
| NCT number | NCT00280696 |
|---|---|
| Title | A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures |
| Official title | A Double-blind, Randomized, Placebo-controlled 5 Parallel Groups, Confirmatory Trial on the Efficacy and Safety of Levetiracetam Used as add-on Therapy at Doses of 0.5 to 3 g/Day in Patients From 16 to 65 Years With Epilepsy With Partial Onset Seizures Under Treatment With 1 to 3 Anti-epileptic… |
| Lead sponsor | UCB Japan Co. Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsies, Partial |
| Intervention type | Drug, Other |
| Interventions | Levetiracetam 250 mg, Levetiracetam 500 mg, Placebo |
| Enrollment | 352 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 23, 2006 |
| Last update posted | Feb 11, 2015 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: